Michał Pogoda

Michał Pogoda

Auto-generated profile, based on publicly available information

Michał Pogoda

Pomeranian Medical University In Szczecin, Szczecin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2025 in JITSS (Journal of Innovation and Trend in Social Sciences)
Verified
Journal Article
Open access
PDF file
WDWiktor Daniszewski
Wiktor Daniszewski
WKWiktoria Knobelsdorf
Wiktoria Knobelsdorf
GFGabriela Furtak
Gabriela Furtak
MŁMaria Łagódka
Maria Łagódka
MPMichał Pogoda
Michał Pogoda
WKWojciech Karchut
Wojciech Karchut
Phosphodiesterase type 5 inhibitors (PDE5Is) are widely prescribed for erectile dysfunction; however, growing evidence indicates that their pharmacological effects extend beyond urological indications and involve multiple organ systems. This narrative review aims to synthesize and critically evaluate current evidence on the systemic effects of PDE5 inhibitors across cardiovascular, renal, neurological, and urological domains, as well as emerging therapeutic indications. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science for studies published up to May 2024, including preclinical studies, clinical trials, observational studies, systematic reviews, and meta-analyses. The reviewed evidence demonstrates that PDE5 inhibitors are associated with reduced cardiovascular morbidity and mortality, improvements in cardiac and pulmonary hemodynamics, preservation of renal function in diabetic populations, potential neuroprotective effects against cognitive decline and ischemic stroke, and symptomatic improvement in benign prostatic hyperplasia and lower urinary tract symptoms. Additional benefits have been reported in conditions characterized by vascular dysfunction, such as angina pectoris and Raynaud’s phenomenon. Overall, PDE5 inhibitors represent a pharmacologically versatile drug class with clinically relevant systemic effects beyond erectile dysfunction, supporting their potential role as adjunctive therapies in broader disease management, although further well-designed randomized controlled trials are needed to inform clinical guidelines.

19 November 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KZKatarzyna Zając
Katarzyna Zając
BOBartosz Oder
Bartosz Oder
DPDominika Marianna Pietrzyk
Dominika Marianna Pietrzyk
GFGabriela Furtak
Gabriela Furtak
MŁMaria Łagódka
Maria Łagódka
MĆMaciej Ćmil
Maciej Ćmil
Background. Physical activity is a key lifestyle factor influencing fertility. As more women delay pregnancy, it's important they understand which modifiable factors can impact their reproductive health. Aim. The aim of this article is to give women more accurate information. Present the data that is currently available to demonstrate how often, how intense, and which exercises are ideal for their reproductive system health when they participate in a sport that will help them keep or improve their fertility. Material and methods. A comprehensive literature search was conducted using PubMed, GoogleScholar, and WebScience databases, focusing on the following keywords: female fertility, physical activity, reproduction health, lifestyle factors and exercise. The search covered publications from 2002 to 2025. Results. Light to moderate physical activity (6 METs) improves ovulation and conception rates in overweight or obese women. However, prolonged intense exercise combined with a low-calorie diet can disrupt the hypothalamic-pituitary-gonadal axis, leading to irregular periods, anovulation, or secondary amenorrhea. Conclusions. One significant and modifiable component in the control and improvement of female fertility should be physical activity. However, light to moderate exercise is good for you and should be promoted, especially for women who have metabolic disorders or lead sedentary lives. The vigorous exercise may have a detrimental effect on reproductive health, apart from women who are overweight or obese.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
DPDominika Marianna Pietrzyk
Dominika Marianna Pietrzyk
GFGabriela Furtak
Gabriela Furtak
MŁMaria Łagódka
Maria Łagódka
KZKatarzyna Zając
Katarzyna Zając
BOBartosz Oder
Bartosz Oder
MĆMaciej Ćmil
Maciej Ćmil
Background: Regular physical activity and exercise during pregnancy, in the absence of contraindications, is recommended and recognized as safe and beneficial for both the mother and the developing fetus. However, contact sports, where the risk of injury is significantly higher, should be avoided. The peripartum period is considered a significant risk factor for the development of mental health issues, particularly postpartum depression (PPD). Aim: This review first presents aspects of the changes in physiology in the mother and fetus. Then the risks and contraindications are discussed, and the various forms of activity are briefly described about their safety, including pelvic-floor muscle exercises and their impact on the course of labor as well as recovery afterwards. Material and methods: Studies, clinical trials, meta-analyses and systematic reviews with quantifiable or qualitative sports and physical activity during pregnancy data. Results: There is now plenty of evidence for the beneficial effects of moderate exercise during pregnancy, even in previously inactive women. Conclusions: Exercise can help reduce the risk of gestational diabetes, pre-eclampsia and cesarean section, while preventing excessive weight gain especially in obese patients. A reduced incidence of postpartum depression has been associated with returning to physical exercise and sports after pregnancy.

23 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MŁMaria Łagódka
Maria Łagódka
GFGabriela Furtak
Gabriela Furtak
DPDominika Marianna Pietrzyk
Dominika Marianna Pietrzyk
KZKatarzyna Zając
Katarzyna Zając
WKWiktoria Knobelsdorf
Wiktoria Knobelsdorf
MPMichał Pogoda
Michał Pogoda
Introduction: Obesity is a chronic metabolic disease characterized by excessive fat accumulation and a multifactorial etiology. One potential contributing factor is impaired executive functioning in individuals with obesity, including deficits in planning, decision-making, and inhibitory control. These impairments may lead to increased impulsivity and difficulties with self-regulation in the context of eating behavior, ultimately contributing to excessive body weight and challenges in achieving weight reduction. The primary brain region responsible for executive functions is the prefrontal cortex. Aim of the study: This review aims to synthesize recent research on the relationship between obesity and executive functions, with particular focus on the prefrontal cortex as both a key modulator of these cognitive processes and a potential target for therapeutic interventions in the management of excessive body weight. Methods: This review was compiled through an extensive analysis of the PubMed and Google Scholar databases. It includes a literature review from [insert year range], with particular emphasis on articles from the past 5 years focusing on the keywords: „obesity”, „prefrontal cortex”, „executive function”, „cognitive function”. Conclusions: Obesity represents a growing health problem with significant clinical and social consequences. Alterations in the prefrontal cortex observed in individuals with obesity may lead to impairments in executive functions, such as reduced impulse control and decision-making difficulties. These dysfunctions can contribute to the development of obesity, while obesity itself may further exacerbate them, creating a vicious cycle. Therefore, interventions aimed at enhancing executive functions could serve as a valuable complement to obesity treatment. However, further consistent research is needed to determine their effectiveness and practical applicability.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MĆMaciej Ćmil
Maciej Ćmil
WKWojciech Karchut
Wojciech Karchut
GFGabriela Furtak
Gabriela Furtak
WDWiktor Daniszewski
Wiktor Daniszewski
WKWiktoria Knobelsdorf
Wiktoria Knobelsdorf
KZKatarzyna Zając
Katarzyna Zając
Introduction: Rhodiola rosea is a widely used adaptogenic herb known for its potential to enhance the body’s resistance to physical and psychological stress. Traditionally employed in various medical systems, it has recently gained scientific attention for its beneficial effects on mood regulation, stress reduction, and cognitive performance. The complex phytochemical composition of Rhodiola rosea underpins these effects, yet the precise mechanisms and clinical efficacy remain to be fully elucidated. This review aims to comprehensively summarize current knowledge regarding the phytochemistry, mechanisms of action, preclinical and clinical evidence of Rhodiola rosea’s adaptogenic properties, focusing on its impact on stress reduction, mood enhancement, and cognitive function. Mechanisms of action involving modulation of the hypothalamic-pituitary-adrenal (HPA) axis, neurotransmitter systems, and antioxidant pathways are discussed. Despite promising results, further high-quality, large-scale randomized controlled trials are needed to establish standardized protocols for clinical use. Material and methods: A systematic literature analysis was conducted, including in vitro, animal, and human studies investigating Rhodiola rosea extracts. Emphasis was placed on studies examining biochemical pathways, neurobehavioral outcomes, and clinical trials assessing stress-related parameters, mood states, and cognitive metrics. Results: Rhodiola rosea exhibits modulatory effects on monoaminergic neurotransmission, enhances antioxidant defenses by upregulating enzymes such as superoxide dismutase and catalase, and improves mitochondrial function, leading to increased cellular energy production. Clinical studies demonstrate significant reductions in perceived stress and fatigue, improvements in mood disorders including mild to moderate depression, and enhanced psychomotor performance and cognitive processing speed. However, variability in extract standardization and study design influences the consistency of findings. Conclusions: Rhodiola rosea represents a promising natural adaptogen with multifaceted actions supporting stress resilience, mood stabilization, and cognitive enhancement. Standardized extracts with defined phytochemical profiles are essential to ensure reproducible therapeutic effects. Further rigorous clinical investigations are warranted to clarify optimal dosing regimens and long-term safety.

26 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MPMichał Pogoda
Michał Pogoda
DPDominika Marianna Pietrzyk
Dominika Marianna Pietrzyk
GFGabriela Furtak
Gabriela Furtak
MŁMaria Łagódka
Maria Łagódka
KZKatarzyna Zając
Katarzyna Zając
BGBartłomiej Gałuszka
Bartłomiej Gałuszka
Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting up to 20% of women of reproductive age worldwide. A central feature of PCOS is insulin resistance (IR), which contributes to hyperandrogenism and worsens reproductive and metabolic symptoms. Given the growing prevalence of PCOS and the widespread use of artificial sweeteners (AS) as sugar substitutes, their potential influence on metabolic health in this population warrants closer examination. Aim: This review aims to assess the current literature on the effects of artificial sweeteners on insulin resistance in women with PCOS, to determine whether their use may exacerbate or mitigate metabolic dysfunctions associated with the syndrome. Methods: A narrative literature review was conducted using the most recent and relevant publications. The review focuses on the biochemical and physiological mechanisms of AS, including their effect on cephalic phase insulin secretion, pancreatic beta-cell response, gut microbiota composition, and hormonal signalling related to glucose metabolism and insulin sensitivity. Results: The impact of AS on metabolic health appears to be heterogeneous and dose-dependent. Some sweeteners, such as saccharin and sucralose, may influence insulin secretion and gut microbiota in ways that contribute to glucose intolerance and IR. However, evidence is inconsistent and varies by sweetener type and study model. In PCOS patients, where IR is a core pathological feature, the use of certain artificial sweeteners may potentially worsen metabolic outcomes. Conclusion: Artificial sweeteners are not metabolically inert and may affect insulin resistance in women with PCOS. Further research is needed to evaluate individual AS compounds and their long-term metabolic effects in this population, in order to inform dietary recommendations and optimize treatment outcomes.